Giant lung cavity due to three different pathogens in a patient receiving inhaled salmeterol plus fluticasone propionate for asthma

References

• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. (GINA, 2023). Available from: https://www.ginasthma.org. [last accessed 13 Sept 2023].
   Google Scholar
• Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100(8):1307–1317. doi:10.1016/j.rmed.2005.11.020.
   PubMed Web of Science ®Google Scholar
• Kachroo P, Stewart ID, Kelly RS, Stav M, Mendez K, Dahlin A, Soeteman DI, Chu SH, Huang M, Cote M, et al. Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma. Nat Med. 2022;28(4):814–822. doi:10.1038/s41591-022-01714-5.
   PubMed Web of Science ®Google Scholar
• Chellaih P, Sivadas G, Chintu S, Vaishnavi Vedam VK, Arunachalam R, Sarsu M. Effect of anti-asthmatic drugs on dental health: a comparative study. J Pharm Bioallied Sci. 2016;8(Suppl 1):s77–S80. doi:10.4103/0975-7406.191973.
   PubMedGoogle Scholar
• Persaud PN, Tran AP, Messner D, Thornton JD, Williams D, Harper LJ, Tejwani V. Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life. Ann Allergy Asthma Immunol. 2023;131(6):745–751.e11. doi:10.1016/j.anai.2023.08.595.
   PubMed Web of Science ®Google Scholar
• Brassard P, Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med. 2011;183(5):675–678. doi:10.1164/rccm.201007-1099OC.
   PubMed Web of Science ®Google Scholar
• Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax. 2013;68(12):1105–1113. doi:10.1136/thoraxjnl-2012-203175.
   PubMed Web of Science ®Google Scholar
• Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, Buhl R, Cruz AA, Fleming L, Inoue H, et al. GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J. 2019;53(6):1901046. doi:10.1183/13993003.01046-2019.
   PubMed Web of Science ®Google Scholar
• Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(3):776–781. doi:10.1016/j.jaip.2018.01.025.
   PubMed Web of Science ®Google Scholar
• Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008;21(2):305–333. doi:10.1128/CMR.00060-07.
   PubMed Web of Science ®Google Scholar
• Yu I, Park S, Hong SH, Chang MS, Lee SJ, Yong SJ, Lee WY, Kim SH, Lee JH. Risk of tuberculosis caused by fluticasone propionate versus budesonide in chronic obstructive pulmonary disease: a nationwide population-based study. J Pers Med. 2022;12(7):1189. doi:10.3390/jpm12071189.
   PubMed Web of Science ®Google Scholar
• Turan M, Ekin S, Ucler R, Arısoy A, Bayram Y, Yalınkılıç A, Bozan N, Garca MF, Çankaya H. Effect of inhaled steroids on laryngeal microflora. Acta Otolaryngol. 2016;136(7):699–702. doi:10.3109/00016489.2016.1146409.
   PubMed Web of Science ®Google Scholar
• Begley LA, Opron K, Bian G, Kozik AJ, Liu C, Felton J, Wen B, Sun D, Huang YJ. Effects of fluticasone propionate on klebsiella pneumoniae and gram-negative bacteria associated with chronic airway disease. mSphere. 2022;7(6):e0037722. doi:10.1128/msphere.00377-22.
   PubMed Web of Science ®Google Scholar
• Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, Durocher A. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect. 2005;11(6):427–429. doi:10.1111/j.1469-0691.2005.01143.x.
   PubMed Web of Science ®Google Scholar
• Doğan M, Şahiner ÜM, Ataç AS, Ballıkaya E, Soyer ÖU, Şekerel BE. Oral health status of asthmatic children using inhaled corticosteroids. Turk J Pediatr. 2021;63(1):77–85. doi:10.24953/turkjped.2021.01.009.
   PubMed Web of Science ®Google Scholar
• Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A, Cervantes J, Diaz PI, Dongari-Bagtzoglou A. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol. 2014;16(2):214–231. doi:10.1111/cmi.12216.
   PubMed Web of Science ®Google Scholar
• Demirbas S, Ozer F. Tuberculin skin test sensivity in asthma patients. Euro Res J. 2011;38:p4075–Epub 2022.
   Google Scholar
• Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA) September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000; Apr 161(4 Pt 2):S221–47. doi:10.1164/ajrccm.161.supplement_3.ats600.
   Google Scholar